Novel immunotherapy targets common cancer mutation, offering hope for lung and prostate cancer patients
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as lung and…